Trials / Completed
CompletedNCT06414018
Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment
Effect of Equivalent Dose of Alfentanil and Sufentanil Combined With Remimazolam in Complex Bronchoscopic Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The equivalent dose of sufentanil and afentanil combined with laryngeal mask was used for complex bronchoscopy to observe the intraoperative effect and the influence on the recovery of patients
Detailed description
Afentanil is a powerful, fast-acting narcotic analgesic, which can effectively inhibit intubation reflex. Compared with sufentanil, it has a short half-life and is safer, and can be used as the first choice for short surgical analgesics. In this study, by comparing the use of equivalent dose sufentanil and afentanil combined with laryngeal mask for complex bronchoscopy, the intraoperative analgesic effect and the influence on the recovery of patients were observed, and a better anesthesia scheme was provided for tracheoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfentanil | alfentanil 10ug/kg is used for anesthesia induction |
Timeline
- Start date
- 2024-05-20
- Primary completion
- 2024-12-25
- Completion
- 2024-12-28
- First posted
- 2024-05-14
- Last updated
- 2025-01-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06414018. Inclusion in this directory is not an endorsement.